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Drug consumption rooms (DCRs), also called safe injecting 
facilities (SIF) and Supervised Drug Consumption Facilities 
(SDCF) amongst various other terms, are legally sanctioned 
and professionally supervised facilities that provide safe and 
hygienic conditions for people who use drugs (PWUD) to 
consume pre-obtained drugs in a non-judgemental environ-
ment.
Goals
• Prevent death from drug overdose
• Reduce drug use and related nuisance in public spaces
• Prevent transmission, and enable testing, of communi-
cable diseases (e.g. HIV, HCV, STIs, TB)
• Reach the most marginalised PWUD who do not access 
other services1
• Provide primary physical and mental health care
• Promote access to other voluntary health, housing, 
social, economic, and legal services, including evi-
dence-based drug detoxification and treatment2, 3
• Provide specialised support to women who use drugs
• Provide ‘real-time’ drug market monitoring data to alert 
PWUD and public health professionals of dangerous 
substances circulating in the community
• Promote voluntary behaviour change, including safer 
approaches to drug use
Benefits
• Enables safe oversight of self-administration of street 
drugs by trained medical professionals
• Access to sterile equipment and related paraphernalia
• Reduces drug use and drug dealing in public spaces
• Prevents death due to drug overdose through immedi-
ate resuscitation by trained medical staff
• Provides primary medical and mental health care to 
the most marginalised PWUD, including women
• PWUD can learn of their HIV, HCV, STI and TB status 
through confidential on-site tests & referral for treatment
• Staff can guide and motivate PWUD on safer drug use 
practices and sexual health information and commodi-
ties, such as condoms and lubricant
• Staff can alert, motivate and support PWUD to access 
other support services through voluntary referral
• Provides ‘real-time’ drug market monitoring to identify 
trends in overdose outbreaks, drug types, and purity to 
inform community education & public health strategies
• Some DCRs provide drinks, food, clothes, showers, use 
of a phone, internet access and a safe space to relax
Evidence4, 5, 6, 7
• DCRs reduce drug overdose deaths within their service 
areas8 and their facilities, resulting in fewer emergency 
service call-outs to overdoses
• DCRs reduce blood borne infections, e.g. HIV & HCV
• DCRs do not increase drug use in the area, nor do they 
encourage people to initiate drug use
• Needle-sharing is reduced or eliminated among PWUD
• Drugs are used in a safer manner, including the cessa-
tion of injecting
• DCRs reduce drug use and impact on drug sales
• DCRs reduce public injecting and reduce the number 
of syringes discarded in the vicinity
• Crime and public nuisance decreases in areas around 
DCRs and substantially contributes to the effective 
management of open drug scenes
• DCRs reduce noise complaints and public safety con-
cerns in the community without attracting young peo-
ple or users from places outside the area
• DCRs provide access to other health and support ser-
vices including opioid substitution therapy (OST), drug 
detoxification and treatment
• DCRs effectively reach, and stay in contact with, highly 
marginalised PWUD
• DCRs result in substantial savings in health care costs in 
the medium-to-long term9
DCR models
DCR models include integrated (I), specialised /  stand-
alone (S), and mobile (M), as outlined below:
DRUG CONSUMPTION ROOMS  
Services Available I S M
Comprehensive range of support services 
under a single roof / ‘one-stop-shop’
Services delivered in multiple locations
Provides sterile equipment and related para-
phernalia for safer drug use
Space for safe drug consumption
Emergency resuscitation services
Provision of primary health care services
Exchange and safe disposal of drug use 
equipment and related paraphernalia
On-site testing for communicable diseases
Provision of other health & social services
Referral to other forms of support
Provision of food, clothing, showers, etc.
Activity programmes
Less common DCR models include Housing/Shelter Facility 
with DCR which allows drugs to be used in designated parts 
of the living/housing facility; often age restricted; unsuper-
vised drug use may still occur; provides the possibility of con-
necting with other services and in sharing experiences with 
residents. Overdose Prevention Sites are temporary super-
vised facilities that operate as ‘lifeguard stations’ for PWUD.
Criteria10, 11
There are various criteria for establishing and operating DCRs 
that are based on the policies of local authorities and na-
tional legislation, as well as the specific setting and access to 
target groups.
To abide by relevant national legislation, drugs used in 
the DCR must be obtained prior to entry and explicit drug 
dealing or sharing is not allowed within the DCR, with staff 
required to cooperate with police when necessary12. DCR 
staff must not assist clients in administering their drug(s) and 
services for women who use drugs should be supervised by 
female staff.
Countries with officially recognised DCRs13
Australia: since 2001; 2 sites in 2 cities
Belgium: since 2019; 2 sites in 2 cities
Canada: since 2003; 39 sites in 4 provinces
Denmark: since 2012; 5 sites in 4 cities
France: since 2016; 2 sites in 2 cities
Germany: since 1994; 24 sites in 15 cities
Luxembourg: since 2005; 1 site
Netherlands: since 1990; 31 sites in 25 cities
Norway: since 2005; 2 sites in 2 cities
Portugal: since 2019; 3 sites in 1 city
Slovenia: since 2015; 1 site in 1 city
Spain: since 2000; 13 sites in 7 cities
Switzerland: since 1986; 12 sites in 8 cities
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Unofficial DCRs also operate in Mexico (1 fixed site), Scot-
land (1 mobile), and Ukraine (1 fixed site). Countries with 
concrete plans to open DCRs include Finland, Greece, Ice-
land, and Scotland. Increasing pressure is being put on the 
governments of the following countries to establish DCRs: 
Austria, England, Ireland, Romania, Sweden, and various 
States of the USA.
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